Position history for BAKER BROS. ADVISORS LP's holdings in CENTESSA PHARMACEUTICALS PLC
BAKER BROS. ADVISORS LP holds 670,751 shares of CNTA (CENTESSA PHARMACEUTICALS PLC), worth $26.6M as of 2026-Q1. CNTA represents 0.2% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$26.6M
Current Shares
670,751
Total Value Change
+$21.7M
Total Shares Change
+121,539
Other major holders of CNTA: Avoro Capital Advisors LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Pentwater Capital Management LP
Unchanged |
| 670,751 |
0.0% |
| $26.6M |
| 0.2% |
| $26.20 |
0 |
| 2025-Q4 | New | 670,751 | - | $16.8M | 0.1% | $24.74 | 39 |
| 2025-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $13.13 | 0 |
| 2025-Q1 | Unchanged | 1.2M | 0.0% | $17.6M | 0.2% | $14.59 | 0 |
| 2024-Q4 | Unchanged | 1.2M | 0.0% | $20.6M | 0.2% | $16.35 | 0 |
| 2024-Q3 | Increased | 1.2M | +123.4% | $19.6M | 0.2% | $15.79 | 55 |
| 2024-Q2 | New | 549,212 | - | $5M | 0.1% | $9.03 | 37 |